TherapeuticsMD, Inc. Gains 82.54%
Thu, Jan 02, 2025 at 07:08 PM
TherapeuticsMD, Inc. (TXMD:NASDAQ) soared at $1.57, representing a gain of 82.5%. On Thu, Jan 02, 2025, TXMD:NASDAQ touched a New 2-Week High of $1.57. The stock appeared on our News Catalysts scanner on Sat, Dec 07, 2024 at 11:00 PM in the 'ACQUISITION' category. From Thu, Dec 19, 2024, the stock recorded 37.50% Up Days and 44.44% Green Days
About TherapeuticsMD, Inc. (TXMD:NASDAQ)
TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.
Top 10 Gainers:
- N2OFF Inc. (NITO:NASDAQ), 331.45%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 140.06%
- Smart for Life Inc. (SMFL:NASDAQ), 132.18%
- TherapeuticsMD, Inc. (TXMD:NASDAQ), 82.54%
- Crown LNG Holdings Limited (CGBS:NASDAQ), 69.48%
- SuperCom Ltd. (SPCB:NASDAQ), 59.34%
- Quantum-Si Incorporated (QSI:NASDAQ), 57.78%
- Heartcore Enterprises Inc. (HTCR:NASDAQ), 56.47%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 51.85%
- Passage Bio, Inc. (PASG:NASDAQ), 46.36%